Deferred Tax Assets, Valuation Allowance of Oncotelic Therapeutics, Inc. from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Oncotelic Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
  • Oncotelic Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $12,760,000, a 4.7% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Oncotelic Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $12,760,000 -$630,000 -4.7% 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q4 2023 $13,390,000 -$45,470,000 -77% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q4 2022 $58,860,000 -$8,818,000 -13% 31 Dec 2022 10-K 12 Apr 2024 2023 FY
Q4 2021 $67,678,000 +$822,000 +1.2% 31 Dec 2021 10-K/A 20 Apr 2023 2022 FY
Q3 2021 $67,633,000 30 Sep 2021 10-Q 22 Nov 2021 2021 Q3
Q2 2021 $67,069,000 30 Jun 2021 10-Q 20 Aug 2021 2021 Q2
Q1 2021 $66,256,000 31 Mar 2021 10-Q 24 May 2021 2021 Q1
Q4 2020 $66,856,000 +$1,502,000 +2.3% 31 Dec 2020 10-K 15 Apr 2022 2021 FY
Q4 2019 $65,354,000 +$2,461,000 +3.9% 31 Dec 2019 10-K 15 Apr 2021 2020 FY
Q4 2018 $62,893,000 +$590,000 +0.95% 31 Dec 2018 10-K 10 Apr 2019 2018 FY
Q4 2017 $62,303,000 -$29,213,000 -32% 31 Dec 2017 10-K 10 Apr 2019 2018 FY
Q4 2016 $91,516,000 +$4,757,000 +5.5% 31 Dec 2016 10-K 17 Apr 2018 2017 FY
Q4 2015 $86,759,000 +$4,300,000 +5.2% 31 Dec 2015 10-K 30 Mar 2017 2016 FY
Q4 2014 $82,459,000 +$3,878,000 +4.9% 31 Dec 2014 10-K 25 Mar 2016 2015 FY
Q4 2013 $78,581,000 +$2,642,000 +3.5% 31 Dec 2013 10-K 30 Mar 2015 2014 FY
Q4 2012 $75,939,000 -$195,000 -0.26% 31 Dec 2012 10-K 20 Mar 2014 2013 FY
Q4 2011 $76,134,000 31 Dec 2011 10-K 15 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.